Beer TM - Search Results

1

Evolving Intersection Between Inherited Cancer Genetics and Therapeutic Clinical Trials in Prostate Cancer: A White Paper From the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium.

Carlo MI, Giri VN, Paller CJ, Abida W, Alumkal JJ, Beer TM, Beltran H, George DJ, Heath EI, Higano CS, McKay RR, Morgans AK, Patnaik A, Ryan CJ, Schaeffer EM, Stadler WM, Taplin ME, Kauff ND, Vinson J, Antonarakis ES, Cheng HH. Carlo MI, et al. Among authors: beer tm. JCO Precis Oncol. 2018;2018:PO.18.00060. doi: 10.1200/PO.18.00060. Epub 2018 Aug 16. JCO Precis Oncol. 2018. PMID: 30761386 Free PMC article.

2

Phase I study of weekly mitoxantrone and docetaxel before prostatectomy in patients with high-risk localized prostate cancer.

Beer TM, Garzotto M, Lowe BA, Ellis WJ, Montalto MA, Lange PH, Higano CS. Beer TM, et al. Clin Cancer Res. 2004 Feb 15;10(4):1306-11. doi: 10.1158/1078-0432.ccr-1021-03. Clin Cancer Res. 2004. PMID: 14977829 Clinical Trial.

3

Neoadjuvant mitoxantrone and docetaxel for high-risk localized prostate cancer.

Garzotto M, Myrthue A, Higano CS, Beer TM. Garzotto M, et al. Among authors: beer tm. Urol Oncol. 2006 May-Jun;24(3):254-9. doi: 10.1016/j.urolonc.2005.11.034. Urol Oncol. 2006. PMID: 16678060 Clinical Trial.

4

Phase II study of KOS-862 in patients with metastatic androgen independent prostate cancer previously treated with docetaxel.

Beer TM, Higano CS, Saleh M, Dreicer R, Hudes G, Picus J, Rarick M, Fehrenbacher L, Hannah AL. Beer TM, et al. Invest New Drugs. 2007 Dec;25(6):565-70. doi: 10.1007/s10637-007-9068-1. Epub 2007 Jul 7. Invest New Drugs. 2007. PMID: 17618407 Clinical Trial.

5

Prostate specific antigen only androgen independent prostate cancer: natural history, challenges in management and clinical trial design.

Ryan CJ, Beer TM. Ryan CJ, et al. Among authors: beer tm. J Urol. 2007 Sep;178(3 Pt 2):S25-9. doi: 10.1016/j.juro.2007.03.136. Epub 2007 Jul 20. J Urol. 2007. PMID: 17644122 Review.

6

Darbepoetin alfa administered every 4 weeks for anemia in patients with advanced prostate cancer.

Beer TM, Bergenstock M, Birt K, Higano CS. Beer TM, et al. Clin Genitourin Cancer. 2007 Jun;5(5):329-33. doi: 10.3816/CGC.2007.n.012. Clin Genitourin Cancer. 2007. PMID: 17645830

7

Molecular alterations in prostate carcinomas that associate with in vivo exposure to chemotherapy: identification of a cytoprotective mechanism involving growth differentiation factor 15.

Huang CY, Beer TM, Higano CS, True LD, Vessella R, Lange PH, Garzotto M, Nelson PS. Huang CY, et al. Among authors: beer tm. Clin Cancer Res. 2007 Oct 1;13(19):5825-33. doi: 10.1158/1078-0432.CCR-07-1037. Clin Cancer Res. 2007. PMID: 17908975 Clinical Trial.

8

American Society of Clinical Oncology endorsement of the Cancer Care Ontario Practice Guideline on nonhormonal therapy for men with metastatic hormone-refractory (castration-resistant) prostate cancer.

Basch EM, Somerfield MR, Beer TM, Carducci MA, Higano CS, Hussain MH, Scher HI; American Society of Clinical Oncology. Basch EM, et al. Among authors: beer tm. J Clin Oncol. 2007 Nov 20;25(33):5313-8. doi: 10.1200/JCO.2007.13.4536. Epub 2007 Oct 9. J Clin Oncol. 2007. PMID: 17925542 Review.

9

A phase 2 study of carboplatin plus docetaxel in men with metastatic hormone-refractory prostate cancer who are refractory to docetaxel.

Ross RW, Beer TM, Jacobus S, Bubley GJ, Taplin ME, Ryan CW, Huang J, Oh WK; Prostate Cancer Clinical Trials Consortium. Ross RW, et al. Among authors: beer tm. Cancer. 2008 Feb 1;112(3):521-6. doi: 10.1002/cncr.23195. Cancer. 2008. PMID: 18085595 Free article. Clinical Trial.

10

Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group.

Scher HI, Halabi S, Tannock I, Morris M, Sternberg CN, Carducci MA, Eisenberger MA, Higano C, Bubley GJ, Dreicer R, Petrylak D, Kantoff P, Basch E, Kelly WK, Figg WD, Small EJ, Beer TM, Wilding G, Martin A, Hussain M; Prostate Cancer Clinical Trials Working Group. Scher HI, et al. Among authors: beer tm. J Clin Oncol. 2008 Mar 1;26(7):1148-59. doi: 10.1200/JCO.2007.12.4487. J Clin Oncol. 2008. PMID: 18309951 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

309 results

Search Page

Filters